A large 6q deletion is a common cytogenetic alteration in fibroadenomas, pre-malignant lesions, and carcinomas of the breast.
Maria Grazia Tibiletti(University of Insubria), Roberto Taramelli(University of Insubria), Roberta Cerutti, B Broggi, Fausto Sessa(University of Insubria), Antonella Russo, Francesco Acquati(University of Insubria), Carlo Capella(University of Insubria), Marco Bianchi(University of Insubria), Barbara Bernasconi(Ospedale di Circolo e Fondazione Macchi), Daniela Furlan(University of Insubria)
PubMed
April 1, 2000
Cited by 48
Related Papers
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
|Genetics in Medicine|2019|666
Immunomodulatory Function of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Type 1 Diabetes
|The Journal of Immunology|2009|383
Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers
|Oncotarget|2016|309
Genomic and expression profiling identifies the B‐cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma
|British Journal of Haematology|2005|193